Wells Fargo Reiterates Buy Rating on Bath & Body Works
Wells Fargo maintains a buy rating on Bath & Body Works, with a price target of $26, a 19.16% upside from the current price.
Key Points
- Wells Fargo reiterated its buy rating on Bath & Body Works, Inc. (NYSE:BBWI) with a price target of $26 on June 23, 2026.
- Wells Fargo's $26 price target implies 19.16% upside from Bath & Body Works, Inc.'s ($BBWI) current $21.82 share price.
- BBWI shares traded at $19.63 on Tuesday, with a market cap of $3.96 billion and a P/E ratio of 5.58.
- Insider buying activity includes several purchases on June 11, 2026, by key executives like Interim CFO Tom Javitch.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Wells Fargo reiterated its buy rating on Bath & Body Works, Inc. (NYSE:BBWI) on June 23, 2026. Analyst Ike Boruchow maintained the price target at $26, indicating continued confidence in the company's prospects. Shares of BBWI traded at $19.63 on Tuesday.
Wells Fargo vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in Bath & Body Works
FMR LLC increased its holdings by 3,944,735 shares, bringing its total to 20,888,799 shares valued at approximately $389.99 million, marking a 23.3% increase. BlackRock, Inc. trimmed its position by 1,826,464 shares, holding 19,322,372 shares worth $360.75 million, a decrease of 8.6%. Vanguard Portfolio Management LLC opened a new position with 15,021,767 shares valued at $280.46 million. AQR Capital Management LLC reduced its stake by 405,215 shares, leaving it with 11,040,713 shares valued at $206.13 million, a 3.5% decrease. Meanwhile, D. E. Shaw & Co., Inc. boosted its position significantly by 3,735,358 shares to 9,504,593 shares, valued at $177.45 million, a 64.7% increase.
Bath & Body Works, Inc. Stock Up 13.5%
Shares of Bath & Body Works traded near $19.63 on Tuesday. The company has a market cap of $3.96 billion and a P/E ratio of 5.58. Its stock has a 52-week low of $14.28 and a high of $33.96. The 50-day moving average is $18.81, and the 200-day moving average is $21.55. Bath & Body Works has a beta of 1.387, indicating its stock is more volatile than the market. The current ratio stands at 1.379, with a quick ratio of 0.667.
$BBWI price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
Bath & Body Works reported revenue of $7.25 billion, with a slight revenue decline of 3.2%. It posted an EPS of $3.52, reflecting a net margin of 10.04%. The next earnings announcement is scheduled for August 27, 2026.
Dividend
The company offers an annual dividend rate of $0.80, yielding 3.89% based on current prices. The dividend payout ratio is a conservative 22.73%.
Insider Buying and Selling at Bath & Body Works, Inc.
Recent insider buying activity includes Interim CFO Tom Javitch purchasing 10,309 shares on June 12, 2026. Other executives, including Alessandro Bogliolo, Juan Rajlin, Sarah Nash, Francis Hondal, and Lucy Brady, also bought shares on June 11, 2026, with each acquiring 7,970 shares.
Analysts Set New Price Targets
On June 23, 2026, Wells Fargo maintained its buy rating on Bath & Body Works with a $26 price target. Other firms like Telsey Advisory Group and TD Cowen also maintained their ratings, with targets of $22 and $25, respectively. The consensus target price among 14 analysts is $25.57.
About Bath & Body Works
Bath & Body Works, Inc. is a specialty retailer based in Columbus, Ohio. It sells personal care and home fragrance products, including candles, soaps, lotions, and mists, under the Bath & Body Works brand. The company operates retail stores in the U.S. and Canada, as well as international locations through franchise and licensing agreements. Daniel Heaf serves as CEO, and the company employs around 9,071 people.
Bottom Line
Wells Fargo's reaffirmation of a buy rating on Bath & Body Works underscores ongoing confidence in the retailer's market position. Investors track these analyst ratings for insights into potential stock movements. It's important to note that such ratings are based on past data and may not reflect future performance.
Get Bath & Body Works, Inc. alerts
New 13F filings, insider trades, and analyst moves on $BBWI, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.